e Council for Scientific and Industrial Research (CSIR) on Wednesday launched BGR-34 — the country’s first anti-diabetic ayurvedic drug designed for Type-2 diabetes mellitus, which has been scientifically validated for its efficacy and safety.

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Bengaluru hosts Ayurved Parv 2018
22 February 2018
Aanger is a Warning Bell
11 January 2014
Panel: AYUSH industry should have a different regulator
01 May 2016